Table 3 Markers, abbreviations and references of PBL subsets
From: Immune characteristics and clinical significance of peripheral blood lymphocytes in breast cancer
| Â | Marker | Abbreviation | Reference (%) |
|---|---|---|---|
T cells | CD3 | CD3 + T cells | 67.00 ~ 76.00 |
cytotoxic T (Tc) cells | CD3/CD8 | CD8 + T cells | 21.00 ~ 32.00 |
T Helper (Th) cells | CD3/CD4 | CD4 + T cells | 35.00 ~ 46.00 |
Th/Tc cells | CD3/CD8/CD4 | CD4+/CD8 + cells | 1.09 ~ 2.17 |
regulatory T cells | CD3/CD4/CD25 | Treg cells | 7.48 ~ 15.09 |
PD-L1 + T cells | CD3/CD274 | PD-L1 + T cells | 92.35 ~ 98.18 |
PD-1 + T cells | CD3/CD279 | PD-1 + T cells | 15.96 ~ 26.32 |
LAG-3 + T cells | CD3/CD223 | LAG-3 + T cells | 1.21 ~ 3.03 |
TIM3 + T cells | CD3/CD366 | TIM3 + T cells | 0.90 ~ 2.06 |
CTLA-4 + T cells | CD3/CD152 | CTLA-4 + T cells | 11.06 ~ 28.84 |
B cells | CD19/CD32 | CD19 + CD32 + B cells | 10.36 ~ 16.87 |
naturel killer cells | CD3/CD16/CD56 | NK cells | 11.00 ~ 23.00 |